benzofuran has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, ZZ; Huang, Q; Kang, TS; Leung, CH; Ma, DL; Mok, SW; Wang, W; Wong, VK; Zhong, HJ | 1 |
1 other study(ies) available for benzofuran and Prostatic Neoplasms
| Article | Year |
|---|---|
An anti-prostate cancer benzofuran-conjugated iridium(III) complex as a dual inhibitor of STAT3 and NF-κB.
Topics: Animals; Benzofurans; Cell Line, Tumor; HEK293 Cells; Humans; Iridium; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Prostatic Neoplasms; Random Allocation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |